Skip to content

Analysis of visual quality after three types of Extended Depth of Focus Intraocular Lenses implantation

Analysis of visual quality after three types of Extended Depth of Focus Intraocular Lenses implantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128799
Enrollment
Unknown
Registered
2026-07-26
Start date
2024-02-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Interventions

AM4UH Group:Implantation of Proming aspheric diffractive multifocal IOL(Model: AM4UH)
ICB00 Group:Implantation of Tecnis Eyhance EDOF IOL(Model: ICB00)
DFT015 Group:Implantation of AcrySof IQ Vivity EDOF IOL (Model: DFT015)

Sponsors

Eye Hospital Affiliated to Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with cataracts who are expected to undergo phacoemulsification with intraocular lens (IOL) implantation, with a nuclear hardness of the affected eye of <= grade IV; 2. No significant fundus pathology observed upon OCT and fundus photography examination; 3. Expected to require an intraocular lens with a refractive power ranging from +5.0 D to +34.0 D; 4. Willing to complete all necessary postoperative follow-up visits.

Exclusion criteria

Exclusion criteria: 1. Previous pathological changes in the anterior segment (cornea, anterior chamber, sclera) or posterior segment (uvea, vitreous-retina), including retinal vascular occlusive diseases, retinal detachment or peripheral retinal laser photocoagulation, age-related macular degeneration (ARMD), glaucoma, diabetic retinopathy, retinal pigment dystrophy, and any optic nerve-related pathologies; 2. History of recurrent anterior or posterior segment inflammation; 3. Current or past history of amblyopia or monocular fixation syndrome associated with stereopsis impairment; 4. Any other ocular or systemic comorbidity, in the investigator's medical opinion, that may confound the results of the study; 5. History of any other ocular surgeries, including but not limited to limbal relaxing incisions/astigmatic keratotomy, and laser in situ keratomileusis.

Design outcomes

Primary

MeasureTime frame
visual acuity;Defocus curve;Refraction; Quality of Visual Function;Visual Function 14;Strehl Ratio;Area Ratio;Reading ability;

Secondary

MeasureTime frame
Color Vision;Intraocular Pressure;

Countries

China

Contacts

Public ContactLiu Dongmei

Eye Hospital Affiliated to Shandong University of Traditional Chinese Medicine

13854191223@163.com+86 138 5419 1223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026